Beta-Cell Function and Glycemic Control Following One-Year Vildagliptin Treatment, and after 12-Week Washout, in Drug-Naive Patients with Type 2 Diabetes and Mild Hyperglycemia

被引：0
|
作者：
Bunck, Mathijs C.
Poelma, Marieke
Goede, Diane L.
Van Golen, Larissa W.
Van Genugten, Renate E.
Eekhoff, E. Marelise
Schweizer, Anja
Heine, Robert J.
Foley, James E.
Nijpels, Giel
Diamant, Michaela
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A17 / A17
页数：1
相关论文
共 40 条
  • [11] Sitagliptin monotherapy improved glycemic control and beta-cell function after 18 weeks in patients with type 2 diabetes (T2DM)
    Raz, Itamar
    Hanefeld, Markolf
    Xu, Lei
    Caria, Christine
    Davies, Michael
    Williams-Herman, Debora
    Khatami, Hootan
    DIABETES, 2006, 55 : A462 - A462
  • [12] Continuous Subcutaneous Insulin Infusion Therapy Increased Beta-Cell Function for One Year in Type 2 Diabetes Patients
    Hong, Eun Shil
    Choi, Soo Bong
    An, Hyun Ju
    Noh, Yun H.
    DIABETES, 2017, 66 : A279 - A279
  • [13] Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naive Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial
    Ito, Daisuke
    Inoue, Kazuyuki
    Saito, Daigo
    Hamaguchi, Keiko
    Kaneko, Kimie
    Sumita, Takashi
    Inukai, Kouichi
    Inoue, Ikuo
    Shimada, Akira
    DIABETES THERAPY, 2021, 12 (12) : 3201 - 3215
  • [14] One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rate
    Zurlo, F.
    Trevisan, C.
    Vitturi, N.
    Ravussin, E.
    Salvo, C.
    Carraro, S.
    Siffi, M.
    Iob, I.
    Saller, A.
    Previato, L.
    Sergi, G.
    de Kreutzenberg, S.
    Maran, A.
    Avogaro, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (12) : 1497 - 1507
  • [15] One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rate
    F. Zurlo
    C. Trevisan
    N. Vitturi
    E. Ravussin
    C. Salvò
    S. Carraro
    M. Siffi
    I. Iob
    A. Saller
    L. Previato
    G. Sergi
    S. de Kreutzenberg
    A. Maran
    A. Avogaro
    Journal of Endocrinological Investigation, 2019, 42 : 1497 - 1507
  • [16] Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
    Takahara, Mitsuyoshi
    Shiraiwa, Toshihiko
    Maeno, Yoshifumi
    Yamamoto, Kaoru
    Shiraiwa, Yuka
    Yoshida, Yoko
    Nishioka, Norio
    Katakami, Naoto
    Shimomura, Iichiro
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [17] Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
    Mitsuyoshi Takahara
    Toshihiko Shiraiwa
    Yoshifumi Maeno
    Kaoru Yamamoto
    Yuka Shiraiwa
    Yoko Yoshida
    Norio Nishioka
    Naoto Katakami
    Iichiro Shimomura
    BMC Endocrine Disorders, 22
  • [18] Effects of one-year treatment with canagliflozin or sitagliptin on glycaemic control and beta cell function measures in subjects with type 2 diabetes on metformin plus sulfonylurea
    Schernthaner, G.
    Ferrannini, E.
    Mari, A.
    Tong, C.
    Kawaguchi, M.
    Meininger, G.
    Polidori, D.
    DIABETOLOGIA, 2013, 56 : S398 - S399
  • [19] Blood pressure and fasting lipid changes after 24 weeks' treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naive patients with type 2 diabetes mellitus
    Evans, Marc
    Schweizer, Anja
    Foley, James E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 337 - 340
  • [20] Indices of beta-cell function: association with diabetes control in patients with type 2 diabetes on stable GLP-1 agonist treatment
    Behary, Preeshila
    Godsland, Ian F.
    Baynes, Kevin C.
    PRACTICAL DIABETES, 2014, 31 (05) : 202 - 205
1234